Clemedi AG (Clemedi) develops in vitro diagnostic (IVD) tests for antibiotic resistance and susceptibility in infectious diseases. The company's products include tuberculosis in vitro diagnostic (IVD) test kit is a assay for the detection of drug-resistant tuberculosis provides lineage determination and resistance testing to antibiotics. Its products are used by laboratories to enhance the accuracy and speed of diagnosing drug-resistant infections, particularly in the healthcare sector. Clemedi collaborates with laboratories and distributors to facilitate the distribution of its diagnostic solutions. Clemedi is headquartered in Dietikon, Zurich, Switzerland.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Clemedi AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Clemedi AG Company Overview
- Clemedi AG Company Snapshot
- Clemedi AG Pipeline Products and Ongoing Clinical Trials Overview
- Clemedi AG - Pipeline Analysis Overview
- Clemedi AG - Key Facts
- Clemedi AG - Major Products and Services
- Clemedi AG Pipeline Products by Development Stage
- Clemedi AG Pipeline Products Overview
- Antibiotic Resistance Detection Test - STI
- Antibiotic Resistance Detection Test - STI Product Overview
- Diagnostic Test - STI
- Diagnostic Test - STI Product Overview
- Diagnostic Test - Surgical Site Infection
- Diagnostic Test - Surgical Site Infection Product Overview
- Diagnostic Test - Urinary Tract Infection
- Diagnostic Test - Urinary Tract Infection Product Overview
- Diagnostic Test - Ventilator Associated Pneumonia
- Diagnostic Test - Ventilator Associated Pneumonia Product Overview
- Tuberculini
- Tuberculini Product Overview
- Clemedi AG - Key Competitors
- Clemedi AG - Key Employees
- Clemedi AG - Locations And Subsidiaries
- Head Office
- Recent Developments
- Clemedi AG, Recent Developments
- Jan 31, 2020: A novel in-vitro diagnostic test for drug-resistant tuberculosis and a personalized antibiotic treatment plan
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Clemedi AG Pipeline Products and Ongoing Clinical Trials Overview
- Clemedi AG Pipeline Products by Equipment Type
- Clemedi AG Pipeline Products by Indication
- Clemedi AG, Key Facts
- Clemedi AG, Major Products and Services
- Clemedi AG Number of Pipeline Products by Development Stage
- Clemedi AG Pipeline Products Summary by Development Stage
- Antibiotic Resistance Detection Test - STI - Product Status
- Antibiotic Resistance Detection Test - STI - Product Description
- Diagnostic Test - STI - Product Status
- Diagnostic Test - STI - Product Description
- Diagnostic Test - Surgical Site Infection - Product Status
- Diagnostic Test - Surgical Site Infection - Product Description
- Diagnostic Test - Urinary Tract Infection - Product Status
- Diagnostic Test - Urinary Tract Infection - Product Description
- Diagnostic Test - Ventilator Associated Pneumonia - Product Status
- Diagnostic Test - Ventilator Associated Pneumonia - Product Description
- Tuberculini - Product Status
- Tuberculini - Product Description
- Clemedi AG, Key Employees
- Glossary
- Clemedi AG Pipeline Products by Equipment Type
- Clemedi AG Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Novigenix SA
- CorFlow Therapeutics AG
- AB2 Bio Ltd
